12 results on '"Manso L"'
Search Results
2. Luminal B breast cancer and prognostic value of HER2 overexpression: Retrospective analysis of a single-institution series.
3. Effect of chemotherapy and trastuzumab as adjuvant treatment for small HER2-positive breast cancer: A single-institution experience.
4. Association between bone turnover markers and skeletal-related events in patients with breast cancer and bone metastases on treatment with bisphosphonates: ZOMAR study results at nine months of follow-up.
5. Safety and efficacy of lapatinib (L)-based therapy in heavily pretreated HER2+ metastatic breast cancer (MBC) patients (pts): A single institution experience.
6. Clinical value of circulating epithelial tumor cells and circulating endothelial cells (CTCs/CECs) in patients with HER2-negative recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) as first-line therapy.
7. First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.
8. Phase II trial of topical heparin as treatment for patients (pts) with hand-foot syndrome (HFS) induced by capecitabine (CAP).
9. Safety and efficacy of metronomic nonpegylated liposomal doxorubicin in heavily pretreated advanced breast cancer.
10. DNA-repair gene (DRG) single nucleotide polymorphisms (SNPs) influence on response and survival in stage IV SCCHN patients treated with CDDP-based therapy
11. Paclitaxel, cisplatin, and cyclophosphamide (PCC) first-line chemotherapy for advanced ovarian carcinoma: Long-term results of a phase II study
12. Paclitaxel, cisplatin, and cyclophosphamide (PCC) first-line chemotherapy for advanced ovarian carcinoma: Long-term results of a phase II study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.